Hospitals could reduce unnecessary tests for cardiac diagnostic imaging

Sep 12, 2008

Hospitals that perform cardiac nuclear stress testing under published national practice guidelines could reduce unnecessary testing and, potentially costs, according to a Henry Ford Hospital study.

The study looked at 375 patients who underwent nuclear stress testing at Henry Ford and showed that in the majority of cases, 90 percent, physicians ordered the diagnostic imaging test appropriately using the updated 2007 Appropriateness Criteria of the American Society of Nuclear Cardiology (ACNC) and American College of Cardiology.

However, researchers also found that 21 patients should not have received the test because their patient profile and assessment didn't meet the test criteria under the guidelines. While these patients were considered low risk for nuclear testing, none required additional testing such as a cardiac catheterization and 95 percent of the scans in the group turned up normal.

Karthik Ananth, M.D., a Henry Ford cardiologist and the study's senior author, and cardiology fellow Natesh Lingam will present the findings Friday, Sept. 12 at the American Society of Nuclear Cardiology Conference in Boston.

While the Henry Ford study did not look at cost, researchers theorize there is potential for savings based on their findings. Further study will be required to determine the cost analysis, researchers say.

"We believe there is potential for substantial savings provided hospitals closely adhere to these test-appropriateness criteria for cardiac nuclear testing," says Dr. Ananth.

"When followed, these criteria help physicians ensure the most effective use of cardiac nuclear testing and provide them simple clinical tools to filter out low-risk patients in whom unnecessary testing can be avoided."

These criteria were developed by an expert panel of physicians in response to a Medicare Payment Advisory Commission report showing that cardiac imaging services rose twice the rate of growth of other physician services from 1999-2003. Based originally on existing medical evidence and the most common clinical reasons for ordering stress testing, the criteria were published in 2005 and updated two years later to guide physicians to use nuclear testing more responsibly and cost effectively.

A cardiac nuclear test is a non-invasive procedure that measures arterial blood flow to the heart during physical or chemical stress. When compared to blood flow during rest, the test reflects imbalances of blood flow to the heart's left ventricular muscle tissue – the part of the heart that performs the greatest amount of work pumping blood.

Henry Ford performs about 4,000 cardiac nuclear tests annually, among the lowest in Michigan. Roughly 8 million nuclear tests are performed nationally, nearly double from 10 years ago. Patients are exposed to a small amount of radiation during the four-hour test, which costs about $4,000. Most insurance plans pay for the test.

In the study, Henry Ford researchers evaluated the practice patterns of their own cardiologists and non-cardiologists who ordered a cardiac nuclear test for patients between January-March 2007. The goal was to determine whether physicians adhered to the 52 criteria outlining when a test is appropriate or inappropriate.

The criteria aid physicians in identifying whether a patient should receive the nuclear test based on their medical profile. Of the 52, 27 indicators are listed for appropriate testing, 13 indicators for inappropriate testing and 12 indicators for uncertain, meaning testing may be acceptable but that additional research is needed to determine these criteria are appropriate or inappropriate.

Source: Henry Ford Health System

Explore further: Hormonal therapy for transsexualism safe and effective

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Hormonal therapy for transsexualism safe and effective

21 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments : 0

More news stories

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.

Paralysed with fear: The story of polio

Thanks to vaccination, polio has been pushed to the brink of extinction – but can we finish the job? This is one of the big questions which a Bristol academic addresses in his new book, published next week.

EUROnu project recommends building Neutrino Factory

(Phys.org) —The European Union's Seventh Framework Programme, EUROnu, has submitted its findings to a panel at CERN. Charged with choosing a project to study the nature of matter and antimatter, the project ...

'Ugly' finding: Unattractive workers suffer more

People who are considered unattractive are more likely to be belittled and bullied in the workplace, according to a first-of-its-kind study led by a Michigan State University business scholar.

Sound waves precisely position nanowires

(Phys.org) —The smaller components become, the more difficult it is to create patterns in an economical and reproducible way, according to an interdisciplinary team of Penn State researchers who, using ...